Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82K Sell
178
-29
-14% -$449 ﹤0.01% 518
2026
Q1
$2.8K Sell
207
-29
-12% -$406 ﹤0.01% 488
2025
Q4
$2.94K Buy
236
+2
+0.9% +$22 ﹤0.01% 485
2025
Q3
$2.32K Buy
234
+26
+13% +$253 ﹤0.01% 495
2025
Q2
$1.86K Buy
208
+2
+1% +$17 ﹤0.01% 466
2025
Q1
$1.79K Buy
206
+2
+1% +$21 ﹤0.01% 395
2024
Q4
$2.54K Sell
204
-57
-22% -$701 ﹤0.01% 389
2024
Q3
$3.04K Sell
261
-42
-14% -$485 ﹤0.01% 382
2024
Q2
$3.22K Buy
303
+2
+0.7% +$22 ﹤0.01% 366
2024
Q1
$3.59K Buy
301
+45
+18% +$542 ﹤0.01% 380
2023
Q4
$2.78K Buy
256
+75
+41% +$718 ﹤0.01% 394
2023
Q3
$1.79K Buy
181
+1
+0.6% +$10 ﹤0.01% 413
2023
Q2
$1.8K Buy
180
+1
+0.6% +$10 ﹤0.01% 425
2023
Q1
$1.73K Buy
179
+1
+0.6% +$11 ﹤0.01% 338
2022
Q4
$1.99K Hold
178
﹤0.01% 322
2022
Q3
$1.51K Hold
178
﹤0.01% 326
2022
Q2
$1.86K Buy
178
+1
+0.6% +$11 ﹤0.01% 306
2022
Q1
$1.92K Buy
177
+46
+35% +$606 ﹤0.01% 315
2021
Q4
$1.77K Buy
+131
New +$1.75K ﹤0.01% 315

Other funds holding VTRS

PFS Partners's VTRS Position: Q2 2026 in Review

PFS Partners reduced its Viatris (VTRS) stake by 14% in Q2 2026, selling an estimated $449 and leaving 178 shares worth $2.82K. The position accounts for ﹤0.01% of the portfolio, ranked #518.

PFS Partners first reported a position in VTRS in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.59K in Q1 2024. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • PFS Partners held 178 shares of Viatris worth $2.82K as of Q2 2026.
  • PFS Partners sold 29 Viatris shares in Q2 2026, an estimated $449.
  • Viatris made up ﹤0.01% of PFS Partners's portfolio in Q2 2026, its #518 holding.
  • PFS Partners first reported a position in Viatris in Q4 2021 and has held it in 19 quarters since.
  • PFS Partners's Viatris position peaked at $3.59K in Q1 2024.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.